- Home
- App Analytics
- Gediib Score
- Gediib Score Vs. FBG - Gastroenterologia
Gediib Score vs FBG - Gastroenterologia Usage & Stats
Gediib Score is a tool for auxiliary calculations for the treatment of IBD.
Gediib Score is a tool developed with the objective of unifying the calculation of important indices for the treatment of IBD.
Scores:
Crhon's disease
- Clinical scores
- Adults
- CDAI / IADC
- HBI / IHB
- Montreal Classification
- Pediatric
- PCDAI
- Paris Classification
- Endoscopic Scores
- CDEIS
- SES-CD
- Rutgeerts
- PDAI
Ulcerative Rectocolitis
- Clinical scores
- Adults
- Mayo (partial)
- Mayo (complete)
- Montreal Classification
- Pediatric
- PUCAI
- Paris Classification
- Endoscopic Scores
- Mayo (endoscopic)
Immunizations:
- Immunosuppression in IBD
- Types of vaccine
- Guidelines on immunizations in IBD
- Recommended vaccines for immunosuppressed patients
- Contraindicated vaccines for immunosuppressed patients
- Interval of drugs discontinuation for vaccination with live attenuated vaccines
- Interval between vaccination with attenuated virus and beginning of immunsuppressants / biological
Pregnancy and Lactation
- Risk of the use of medicines use during pregnancy and lactation
- Apple App Store
- Free
- Medical
Store Rank
- -
Este aplicativo é mais uma iniciativa da FBG para seu associado. Nele você poderá manter um canal de contato direto com a Federação, além de ter rápido e fácil acesso a serviços e conteúdos científicos diferenciados. Acesse conteúdos como Congressos e Cursos online, notícias, eventos e muito mais.
- Apple App Store
- Free
- Medical
Store Rank
- -
Gediib Score vs. FBG - Gastroenterologia ranking comparison
Compare Gediib Score ranking trend in the past 28 days vs. FBG - Gastroenterologia
Rank
No Data Available
Gediib Score vs. FBG - Gastroenterologia ranking by country comparison
Compare Gediib Score ranking trend in the past 28 days vs. FBG - Gastroenterologia
No Data to Display
Compare to any site with our free trial
Gediib Score VS.
FBG - Gastroenterologia
December 16, 2024